PMU62 Improved Quality of Life in Children With Progressive Familial Intrahepatic Cholestasis Following 24 Weeks of Treatment With Odevixibat, an Ileal Bile Acid Transporter Inhibitor: Results From the Phase 3 PEDFIC 1 Study
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.774
https://www.valueinhealthjournal.com/article/S1098-3015(21)00991-8/fulltext
Section Title :
Section Order :
10277
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00991-8&doi=10.1016/j.jval.2021.04.774